Articles

Written by AMV

Apple’s hidden threat to Fitbit, Jawbone UP, and Nike Fuel

Skip Fleshman
VentureBeat
November 12, 2013

Much has been made of the iPhone 5S’s new A7 chip, but the new M7 co-processor is, if anything, potentially more disruptive. The M7 will have an impact on the entire development process of mobile apps, and, from my vantage point, will have a profound impact on digital health...

Read more »

Electronic Health Records Market Report

Luke Lee
Whitepaper
August 13, 2013

The healthcare industry is undergoing a meaningful transition to paperless health records that are incentivized by government programs. The goal of achieving an intelligent, more efficient, and cost-saving healthcare system has prompted an era of health information technology. Today, financial incentives and the potential for penalties are the main drivers in adoption of EHR today and will be in the future. Additionally, healthcare information technology companies are establishing beachheads in an EHR market that is dominated by key players. Companies have achieved this by building products that address the need for EHRs, or solutions that integrate with or work around systems that are routinely used today...(Contact info@assetman.com for full report)

Why VCs should love hardware startups

Skip Fleshman
VentureBeat
June 2, 2013

Venture capitalists hate investing in hardware startups for a myriad of reasons. Design and iteration are more difficult. Margins are low. Manufacturing issues are unpredictable. Inventory is expensive to hold and manage. Shipping is costly and cumbersome.

But this paradigm is shifting and venture should think twice before dismissing hardware companies out of hand. Here are some reasons why:...

Read more »

What’s Hot in Digital Health? The Venture Capital Perspective

Skip Fleshman
Xconomy
December 11, 2012

The U.S. healthcare market is ripe for technical disruption. Costs are spiraling out of control while quality of service and customer satisfaction continue to go down. The system is opaque, complex and fragmented. Regulation is required but imposes heavy costs. As in other industries before it, the healthcare sector can benefit from technology-enabled efficiency gains that use measurement tools, structured data, analytics, SaaS, faster processing, smartphones and tablets...

Read more »

Why WebMD Is History: The Next Generation of Web-Based Medicine

Skip Fleshman
Xconomy
March 9, 2012

The healthcare industry has been waiting a long time for its “2.0″ moment. As social networks like Facebook and LinkedIn exploded in the late 2000s, so did e-commerce, enterprise SaaS, and cloud services. Business models, features and strategies have all dramatically evolved in the past decade and the valuations of many IT companies have taken off. But the Health 2.0 transformation is finally here, and it’s going to be profound—dramatically changing the way patients obtain health and wellness information, track their progress, and interact with providers and physicians. It’s going to be an exciting time in Silicon Valley as next-generation information startups address the multi-trillion dollar healthcare market...

Read more »

How to Turn a Mobile Health Application into a Real Business

Skip Fleshman
Xconomy
January 13, 2012

2011 has been a big year for health sciences technology and, specifically, mobile health. Venture capital investors, looking for the next big thing, are beginning to invest in companies developing mobile applications in the health and wellness sector. Smartphones are making new health care applications feasible, and one doesn’t have to look far to see tangible examples of companies creating some buzz. Fitbit, Lark, Zeo, and Jawbone (UP) have all raised capital and developed hardware solutions often tied to Apple’s iOS or Android based phones. Hundreds of companies are targeting weight loss, wellness/ fitness and women’s health with software-only applications. Incubators like Rock Health are popping up, bloggers are beginning to write about the sector, and gamification has become a term commonly used in healthcare. As cleantech investing predictably dies, mobile health and Health 2.0 are taking its place...

Read more »

Tweets

AMV, partners and portfolio companies

News

Quotes contributed by AMV

Where (in the Human Body) Venture Capital Is Going

The Wall Street Journal
September 15, 2014

Investors aren't giving up on treatments for heart disease, and existing drugs for common conditions such as heart failure could be improved upon, says Lou Lange, a partner with Asset Management Ventures.

Read more »

New health apps, games reward patients who take their meds

Reuters
August 15, 2014

But while game-like health apps may work with women, who make up the largest group of mobile gamers, and youth, Skip Fleshman, a health investor at Asset Management Ventures, warned that they may fail to reach a majority of other patients. "I doubt this would be effective for people who can't afford to take drugs or suffer from side effects," he said.

Read more »

Digital Health Check-Up: More Dollars, Fewer Bracelets

Fenwick & West Digital Health Investor Summit
May 12, 2014

“The consumer stuff might be a wave that has passed,” said Asset Management Ventures partner Skip Fleshman, whose 50-year-old firm began looking at digital health five years ago. “There are so many wearables out there, we’re skeptical that people will actually pay [for them].”

Read more »

StartX Med Delivers Daylong Jolt of Medical and Biotechnology Entrepreneurship Resources

StartX Med
February 14, 2014

Investor Skip Fleshman of Asset Management Ventures told his audience that biotech exits have been “white hot” in the past year and a half. He predicted the industry will see an increase in biotech firms jumping back into the market.

Read more »

4 questions raised by Castlight Health IPO filing

MedCity News, February 14, 2014

Skip Fleshman, a partner with Asset Management Ventures, expressed some surprise at the disconnect between the upwards of $2 billion valuation and the stark reality of the balance sheet. Referring to Castlight’s revenue and profitability he said, "It’s pretty anemic and pathetic." But he was reluctant to say whether the company’s performance on the day it goes public will have much of an impact on other digital health companies, though he added, "It’s probably not the best bellwether."

Read more »

Educated guesstimates about Audax Health price tag start at $100M and rise to $400M+

MedCity News
January 31, 2014

Skip Fleshman, a partner with Asset Management Ventures, sees the Audax acquisition as a validation of technology startups, which tend to do a better job of consumer-led products than the healthcare industry has, particularly payers...

Read more »